{
    "Trade/Device Name(s)": [
        "Piccolo\u00ae HDL - Capillary Test System",
        "Piccolo\u00ae HDL Test System",
        "Piccolo\u00ae Lipid Panel - Capillary Reagent Disc"
    ],
    "Submitter Information": "Abaxis, Inc.",
    "510(k) Number": "K120662",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023640",
        "K033610"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JHM"
    ],
    "Summary Letter Date": "March 2, 2012",
    "Summary Letter Received Date": "March 5, 2012",
    "Submission Date": "March 2, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "HDL"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparinized tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Piccolo xpress Chemistry Analyzer",
        "Abaxis Chemistry Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Hybrid enzymatic colorimetric end-point test",
        "Dextran/sulfate precipitation",
        "Centrifugation",
        "PEG-modified enzymes"
    ],
    "Methodologies": [
        "Enzymatic colorimetric assay"
    ],
    "Submission Type(s)": [
        "Test System",
        "Reagent Disc"
    ],
    "Document Summary": "FDA 510(k) summary for Piccolo HDL - Capillary Test System for quantitative HDL measurement using a hybrid enzymatic colorimetric assay on the Piccolo xpress Chemistry Analyzer",
    "Indications for Use Summary": "For in vitro quantitative determination of HDL in capillary (fingerstick) heparinized whole blood in clinical laboratory or point-of-care settings; lipoprotein measurements aid diagnosis and treatment of lipid disorders, atherosclerosis, liver and renal diseases.",
    "fda_folder": "Clinical Chemistry"
}